News Headlines Article

Cancer drugs cost more in U.S.
Modern Healthcare

It’s well-known that Americans pay more for healthcare and drugs than many other nations, and a recent study confirms that the same is true for oncology drugs. A study presented at this week’s American Society of Clinical Oncology’s annual meeting in Chicago has demonstrated large differences in average retail prices for 23 cancer drugs in seven different countries. Prices were highest in the U.S., and lowest in South Africa and India.In a separate measure of affordability, the study found that even though cancer drugs were less expensive in low-income countries, they were less affordable to patients in those countries.